Medtronic plc business relationships
Companies named in Medtronic plc’s 10-K filed 2026-06-18, and public companies whose annual reports name Medtronic plc. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.6 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Layers: Robotics
Named in Medtronic plc’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name Medtronic plc 21
“License Agreement with Medtronic” SEC filing
“We address large surgical and interventional markets in orthopedics, CMF and cardiovascular through collaboration agreements with leading medical device companies, including DePuy Synthes, Zimmer Biomet, Enovis, Abbot, Medtronic and Smith & Nephew.” SEC filing
“In early 2018, Medtronic withdrew SEEQ from the marketplace.” SEC filing
“...have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents covering technology that we license from or license to third parties, including by way of our cross-license with Medtronic, and we are therefore reliant on our licensors or licensees.” SEC filing
“Collaboration: The Company and Medtronic agree to engage in non-exclusive good faith discussions regarding potential collaboration opportunities with respect to manufacturing, co-development and co-commercialization of the Company's products and other matters as may be agreed to between the Company...” SEC filing
“capsule-based imaging solutions manufactured by companies such as Medtronic, IntroMedic, JinShan and Ankon.” SEC filing
“As of December 31, 2025, we do not import materials from Canada or China, but we do source tubing sets from Medtronic that are manufactured in Mexico.” SEC filing
“During 2025, three of our customers, Abbott Laboratories, Boston Scientific and Medtronic were each in excess of 10% of total sales and collectively accounted for 49% of our total sales.” SEC filing
“...pport our critical business functions, including accounting and reporting, manufacturing process control, quality and compliance systems, sales, invoicing, customer service, inventory control, and distribution, in order to replace many of the systems Medtronic provided to us prior to the Separation.” SEC filing
“First Amendment to Integration, Supply and Distribution Agreement, dated as of June 1, 2026, by and between Abbott Diabetes Care, Inc. and Medtronic MiniMed, Inc.” SEC filing
“MGH-MM Intellectual Property Cross-License Agreement, dated as of March 1, 2026, by and between Medtronic MiniMed, Inc. and Medtronic Group Holding, Inc.” SEC filing
“The Pöhlmann 2025 meta-analysis, a systematic literature review and meta-analysis of 34 real-world studies conducted by external researchers in collaboration with Medtronic, evaluated glycemic outcomes across major AID systems.” SEC filing
“In addition, we may be unable to obtain replacement services on similar terms as those provided by Medtronic.” SEC filing
“...estimates factoring epidemiologic data from government and leading industry organizations such as the CDC as well as industry sales data from public filings and disclosures made by the leading device manufacturers (Medtronic, Tandem and Insulet) and aggregated by third-party data service providers.” SEC filing
“In pediatrics, the Carpediem system distributed by Medtronic is indicated for use in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy, and Baxter's HF20 Set is authorized under an Emergency Use Authorization to deliver CRRT to treat patients of low we...” SEC filing
“Additionally, Medtronic and DaVita have recently formed a joint venture, Mozarc Medical, to pursue a variety of kidney applications across each of our customer categories.” SEC filing
“Under the terms of the Medtronic Agreement, assuming that AVIM-enabled devices are sold at average selling prices supported by existing reimbursement structures worldwide (e.g., no higher or additional reimbursement is available), we are expected to receive between $500 and $1,600 per AVIM-enabled d...” SEC filing
“In addition, we concluded Medtronic is a customer for a good or service that is a distinct unit of account, and therefore the transactions in the Medtronic Agreement should be accounted for under ASC 606.” SEC filing
“...ents and 80 issued patents in countries outside of the United States protect CNT, and which are exclusively licensed to Medtronic in the Primary Field pursuant to the Medtronic Agreement; four issued U.S. patents and 14 issued patents in countries outside of the United States protect CNT-HF; and a f...” SEC filing
“Our strategic collaboration agreement with Medtronic for AVIM Therapy demonstrates our ability to align with a global market leader for the long-term development and commercialization of a product candidate.” SEC filing
“The Company previously operated under a non-exclusive license agreement with Medtronic relating to certain valve intellectual property.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.